CD177 and breast carcinoma: αvβ3, αvβ5, and/or α6β4 integrin complex are cell surface receptors of POSTN in CRC, pancreatic cancer, epithelial ovarian carcinoma, esophageal adenocarcinoma, and breast cancer cells [10, 21–23].